Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country crawled time : 00:00 save search
FNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual Meeting
Published: 2024-04-17 (Crawled : 00:00) - biospace.com/
RLYB | News | $1.72 -2.27% 170K
|
|
| O: -4.44%
H: 0.0%
C: 0.0%
pharmacy review care meeting
UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers
Published: 2024-04-17 (Crawled : 00:00) - biospace.com/
URGN | $14.37 0.91% 170K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
association for meeting benefits
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
HOTH | $1.23 10K
|
Health Technology
|
| O: 5.37%
H: 0.64%
C: -12.1%
obesity treatment wholly
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
Published: 2024-03-18 (Crawled : 00:00) - biospace.com/
KRMD | News | $2.11 -0.47% 5.7K
|
Health Technology
|
| O: 0.0%
H: 4.09%
C: -5.45%
conference system medical
New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain
Published: 2024-02-26 (Crawled : 00:00) - biospace.com/
PFE A | $25.325 -0.37% 15M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: -1.77%
TNXP | $0.1586 -0.5% 1M
|
Health Technology
|
| O: 4.32%
H: 7.17%
C: 2.5%
drug fibromyalgia study
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
APDN | $0.35 5.1% 97K
|
Commercial Services
|
| O: 5.0%
H: 0.02%
C: -4.76%
first year dna financial results
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
Published: 2024-02-08 (Crawled : 00:00) - biospace.com/
INSM | $26.21 0.12% 450K
|
Health Technology
|
| O: -0.17%
H: 0.21%
C: -1.28%
conference year financial results
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-07 (Crawled : 00:00) - biospace.com/
INO 2 d | $10.54 -4.79% 180K
|
Health Technology
|
| O: -0.94%
H: 4.69%
C: 0.76%
conference life sciences
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
Published: 2024-01-08 (Crawled : 00:00) - biospace.com/
NUVB A | $2.635 -2.05% 280K
|
|
| O: 0.67%
H: 4.0%
C: 3.33%
nuv-1511 fda drug tumors treatment clearance application advanced
Rocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-02 (Crawled : 00:00) - biospace.com/
RCKT M | $23.61 -0.3% 94K
|
Health Technology
|
| O: -1.47%
H: 3.39%
C: -0.1%
conference pharmaceuticals
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-02 (Crawled : 00:00) - biospace.com/
INSM | $26.21 0.12% 450K
|
Health Technology
|
| O: -0.61%
H: 1.1%
C: -2.79%
conference
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
conference
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
Published: 2023-12-07 (Crawled : 00:00) - biospace.com/
ANGO | $6.325 -0.08% 59K
|
Health Technology
|
| O: 0.89%
H: 3.51%
C: 2.93%
treatment system study
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
Published: 2023-12-04 (Crawled : 00:00) - biospace.com/
BDX | $230.84 -0.59% 300K
|
Health Technology
|
| O: -0.39%
H: 0.52%
C: 0.11%
INOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-09 (Crawled : 00:00) - biospace.com/
INO 2 d | $10.54 -4.79% 180K
|
Health Technology
|
| O: -2.61%
H: 0.73%
C: -2.16%
financial results
SELLAS Provides Business Update and Reports Third Quarter 2023 Financial Results
Published: 2023-11-09 (Crawled : 00:00) - biospace.com/
SLS | $1.45 2.84% 910K
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: -4.21%
business update financial results
Establishment Labs Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 00:00) - biospace.com/
ESTA | News F | $53.405 2.41% 74K
|
Health Technology
|
| O: -0.8%
H: 0.46%
C: -2.85%
financial results
Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
Published: 2023-11-06 (Crawled : 00:00) - biospace.com/
RCKT M | $23.61 -0.3% 94K
|
Health Technology
|
| O: 0.14%
H: 1.81%
C: -5.14%
pharmaceuticals financial results
Annovis Bio Showcases Promising Progress in Novel Drug Development at the 2023 Clinical Trials on Alzheimer's Disease Conference
Published: 2023-10-24 (Crawled : 00:00) - biospace.com/
ANVS | $9.4 4.56% 95K
|
Health Technology
|
| O: 0.76%
H: 7.38%
C: -1.0%
drug conference disease trials alzheimer's
Savara Reports Second Quarter Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 00:00) - biospace.com/
SVRA | $4.925 -0.71% 340K
|
Health Technology
|
| O: 0.81%
H: 5.33%
C: 2.4%
business update financial results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
INVO | $1.36 78.95% 3.6M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
ALRN | $5.53 30.12% 250K
|
Health Technology
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.